Babcock & Wilcox Enterprises, I (BWNB) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Les analystes estiment Bénéfice par action (EPS) de $-0.14 et chiffre d'affaires de $0.86B pour le prochain exercice fiscal.
Historique du Bénéfice par action (EPS): 2024: réel $-0.82 vs est $-0.14 (manqué -472.1%). 2025: réel $-0.48 vs est $-0.37 (manqué -30.9%). Précision des analystes: 47%.
Estimations du BPA — BWNB
47%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.82
vs Est –$0.14
▼ 82.5% off
2025
Actual –$0.48
vs Est –$0.37
▼ 23.6% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Estimations du CA — BWNB
87%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.717B
vs Est $0.864B
▼ 20.5% off
2025
Actual $0.588B
vs Est $0.624B
▼ 6.1% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
Les autres consultent aussi
